With antibiotic resistance on the rise, tuberculosis is emerging as a bigger global health threat than ever before. But now, innovative research at Weill Cornell Medical College suggests that Mycobacterium tuberculosis has an as yet unsuspected weakness -- one that could be a prime target for drug development. "Using novel techniques, we have identified a key membrane protein that's essential to the defense that M.
(more...)